Search research articles
Contact Us
Filters
Showing results (141-150 of 155) with videos related to
Page
of 16
Sort By:
Current Medical Research and Opinion
|
October 5, 2020
Safety of the Xuesaitong injection in China: results from a large-scale multicentre post-marketing surveillance study in a real-world setting
Yan He, Xue-Min Gao, Lei Li, et al.
Thoracic Cancer
|
July 20, 2024
Changes in the recent three decades and survey on the current status of surgical treatment for esophageal cancer in China
Yong Li, Wei-Xin Liu, Ling Qi, et al.
World Journal of Gastroenterology
|
January 13, 2004
Long-term outcome of esophageal myotomy for achalasia
Jun-Feng Liu, Jun Zhang, Zi-Qiang Tian, et al.
Molecular Plant Pathology
|
September 17, 2025
Structural Insights Into the Role of RxLR Effectors in the Arms Race Between Oomycetes and Plants
Yang Liu, Yang Yang Zheng, Xin Ru Zhou, et al.
Injury
|
June 13, 2020
Dynamic limited axial compression yields favorable functional outcomes in the fixation of Pauwels type-3 femoral neck fractures: A retrospective cohort study
Jun-Feng Liu, Shao-Di Zhang, Liang Huang, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]
|
January 29, 2009
[Cox proportional hazard model analysis of prognosis in patients with carcinoma of esophagus and gastric cardia after radical resection]
Wei Liu, Xi-Shan Hao, Qian Fan, et al.
Hepatology International
|
February 17, 2026
TACE and tyrosine kinase inhibitors with or without PD-1 inhibitors as first-line therapy for intermediate-advanced HCC: a multicenter real-world cohort study
Xue-Gang Yang, Li-Wei Deng, Yong Zhao, et al.
Cancer Management and Research
|
July 2, 2020
Icotinib as Adjuvant Treatment for Stage II-IIIA Lung Adenocarcinoma Patients with EGFR Mutation (ICWIP Study): Study Protocol for a Randomised Controlled Trial
Yu-Tao Liu, Xue-Zhi Hao, De-Ruo Liu, et al.
Frontiers in Immunology
|
April 27, 2026
Real-world efficacy and safety of transarterial chemoembolization plus sintilimab and bevacizumab biosimilar for intermediate-advanced hepatocellular carcinoma: a propensity score matching study
Li-Wei Deng, Jun-Feng Liu, Hai-Yan Yu, et al.
European Journal of Radiology
|
September 5, 2025
Predicting tumor response to TACE plus lenvatinib and PD-1 inhibitors for unresectable HCC: A multicenter observational study
Li-Wei Deng, Qing-Yun Xie, Bo Peng, et al.
Page
of 16
Search research articles
Search
Showing results (141-150 of 155) with videos related to
Sort By:
Page
of 16
Current Medical Research and Opinion
|
October 5, 2020
Safety of the Xuesaitong injection in China: results from a large-scale multicentre post-marketing surveillance study in a real-world setting
Yan He, Xue-Min Gao, Lei Li, et al.
Thoracic Cancer
|
July 20, 2024
Changes in the recent three decades and survey on the current status of surgical treatment for esophageal cancer in China
Yong Li, Wei-Xin Liu, Ling Qi, et al.
World Journal of Gastroenterology
|
January 13, 2004
Long-term outcome of esophageal myotomy for achalasia
Jun-Feng Liu, Jun Zhang, Zi-Qiang Tian, et al.
Molecular Plant Pathology
|
September 17, 2025
Structural Insights Into the Role of RxLR Effectors in the Arms Race Between Oomycetes and Plants
Yang Liu, Yang Yang Zheng, Xin Ru Zhou, et al.
Injury
|
June 13, 2020
Dynamic limited axial compression yields favorable functional outcomes in the fixation of Pauwels type-3 femoral neck fractures: A retrospective cohort study
Jun-Feng Liu, Shao-Di Zhang, Liang Huang, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]
|
January 29, 2009
[Cox proportional hazard model analysis of prognosis in patients with carcinoma of esophagus and gastric cardia after radical resection]
Wei Liu, Xi-Shan Hao, Qian Fan, et al.
Hepatology International
|
February 17, 2026
TACE and tyrosine kinase inhibitors with or without PD-1 inhibitors as first-line therapy for intermediate-advanced HCC: a multicenter real-world cohort study
Xue-Gang Yang, Li-Wei Deng, Yong Zhao, et al.
Cancer Management and Research
|
July 2, 2020
Icotinib as Adjuvant Treatment for Stage II-IIIA Lung Adenocarcinoma Patients with EGFR Mutation (ICWIP Study): Study Protocol for a Randomised Controlled Trial
Yu-Tao Liu, Xue-Zhi Hao, De-Ruo Liu, et al.
Frontiers in Immunology
|
April 27, 2026
Real-world efficacy and safety of transarterial chemoembolization plus sintilimab and bevacizumab biosimilar for intermediate-advanced hepatocellular carcinoma: a propensity score matching study
Li-Wei Deng, Jun-Feng Liu, Hai-Yan Yu, et al.
European Journal of Radiology
|
September 5, 2025
Predicting tumor response to TACE plus lenvatinib and PD-1 inhibitors for unresectable HCC: A multicenter observational study
Li-Wei Deng, Qing-Yun Xie, Bo Peng, et al.
Page
of 16